REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 1st, 2024 • AIM ImmunoTech Inc. • Biological products, (no disgnostic substances)
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 28, 2024, is entered into by and between AIM IMMUNOTECH, INC., a Delaware corporation (the “Company”), and ATLAS SCIENCES, LLC, a Utah limited liability company (together with it permitted assigns, the “Investor”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Equity Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
EQUITY PURCHASE AGREEMENTEquity Purchase Agreement • April 1st, 2024 • AIM ImmunoTech Inc. • Biological products, (no disgnostic substances) • Utah
This Equity Purchase Agreement is entered into as of March 28, 2024 (this “Agreement”), by and between AIM ImmunoTech, Inc., a Delaware corporation (the “Company”), and Atlas Sciences, LLC, a Utah limited liability company (the “Investor”, and collectively with the Company, the “Parties”).
